SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve 1.Approval of Standalone Unaudited Financial Results for Q ended 31st December 20242. any other matter with permission of chairman 1.Approval of Standalone Unaudited Financial Results for Q ended 31st December 20242. any other matter with permission of chairman
Sandu Pharmaceuticals Limited Press Release Feb 04 2025
Filed with BSE · · 1 page · English
Release
Sandu Pharmaceuticals Limited on 6ix
Earlier from Sandu Pharmaceuticals
- Sandu Pharmaceuticals Limited Press Release Feb 03 2025
- Sandu Pharmaceuticals Limited Press Release Jan 21 2025
- Sandu Pharmaceuticals Limited Press Release Jan 14 2025
- Sandu Pharmaceuticals Limited Press Release Jan 09 2025
- Sandu Pharmaceuticals Limited Press Release Jan 02 2025
Later from Sandu Pharmaceuticals
- Sandu Pharmaceuticals Limited Press Release Feb 11 2025
- Sandu Pharmaceuticals Limited Press Release Feb 13 2025
- Sandu Pharmaceuticals Limited Press Release Feb 15 2025
- Sandu Pharmaceuticals Limited Press Release Feb 19 2025
- Sandu Pharmaceuticals Limited Press Release Mar 24 2025
Follow Sandu Pharmaceuticals into a list and get an email when it puts out news.
Follow Sandu Pharmaceuticals